Read on Twitter
Interesting study in @JAADjournals with @AMostaghimi finding an inpatient #dermatogy consult service generated only ~$80k/yr in revenue. To be financially viable, will be crucial to capture the significant indirect value of inpatient dermatology. 1/4 https://pubmed.ncbi.nlm.nih.gov/32822800/
We know that misdiagnosed cellulitis imposes significant financial costs and is associated with poorer patient outcomes. Moreover, access to inpatient dermatology consults can improve management of suspected cellulitis. 2/4 https://pubmed.ncbi.nlm.nih.gov/27806170/
Similarly, supportive oncodermatology enables better outcomes for patients being treated for cancer, helping them to stay on the most optimal treatment recommendations from their oncologists (and oncology is generally a significant profit center for most health systems). 3/4
These and other sources of indirect value likely have substantial benefit to the patient and improve profitability of the health system. Measuring this value and ensuring appropriate support of #inpatient #dermatology services will be critical to ensure access. 4/4
